M&A Consultant
Posted 10 Sep 2026
Advertised as “M&A Consultant - Life Sciences”
BranchFactor Summary
The original posting with the fluff stripped out
- Expected experience
- 12+ yrs
- Management level
- People management
- Contract
- Full-time
No salary listed for this role.
Field of studyComputer Science, Engineering, Information Systems, Life Sciences, Pharmacy (or related)
Study levelBachelor's
CertificationsMaster of Business Administration, PharmD, TOGAF
Digital Innovation and M&A Transformation Consultant – Life Sciences
Are you focused on assessing and executing the impact of acquisitions, divestitures, licensing deals, spin-offs, and portfolio restructuring on business processes, data, applications, AI capabilities, and operating models across Commercial, Clinical, Regulatory, Safety, and Quality domains?
About your role
Infosys Consulting is seeking talented and highly motivated consultants to join our Life Sciences practice specializing in Mergers, Acquisitions, Divestitures, and Business Transformation.
As a Senior Principal / Associate Partner, you will help pharmaceutical and biotechnology organizations assess and manage the impact of acquisitions, divestitures, carve-outs, spin-offs, and strategic partnerships across business processes, data ecosystems, and enterprise application landscapes.
You will work with business and technology leaders across Clinical Development, Regulatory Affairs, Safety, Quality, and Commercial organizations to define integration strategies, future-state operating models, and transformation roadmaps that enable rapid value realization while managing regulatory and operational risk.
RESPONSIBILITIES
M&A Assessment and Strategic Planning
· Assess the impact of acquisitions, divestitures, carve-outs, and business restructurings on operating models, business capabilities, processes, data, and technology landscapes.
· Conduct due diligence, integration assessments, and separation planning activities across Life Sciences functions.
· Define Day 1, TSA, Day 100, and target-state integration or separation strategies.
· Advise executive stakeholders on risks, dependencies, governance models, and value realization opportunities.
Business, Data and Technology Transformation
· Analyze the impact of M&A transactions on clinical, regulatory, safety, quality, and commercial business processes.
· Assess enterprise application portfolios and identify integration, coexistence, rationalization, or separation requirements.
· Evaluate data migration, master data management, governance, reporting, and interoperability challenges.
· Develop future-state architectures supporting business and regulatory objectives.
Roadmap Development and Execution
· Define phased integration and separation roadmaps aligned to business priorities and transaction objectives.